Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chemonucleolysis. Method, indications and results. Review].

K Dei-Anang1, D Voth

  • 1Klinik für Neurochirurgie, Universität Mainz.

Zentralblatt Fur Neurochirurgie
|January 1, 1987
PubMed
Summary

Chemonucleolysis (CNL) using discase and collagenase is a supplemental treatment for lumbar disc herniation, achieving about 70% success. It can avoid surgery in select cases but isn't a complete substitute.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bovine pericardium for duraplasty: clinical results in 32 patients.

Neurosurgical review·2001
Same author

Masseter reflex and blink reflex abnormalities in Chiari II malformation.

Muscle & nerve·2001
Same author

Assessment of brainstem function in Chiari II malformation utilizing brainstem auditory evoked potentials (BAEP), blink reflex and masseter reflex.

Brain & development·2000
Same author

Orthopedic and neurosurgical treatment of severe kyphosis in myelomeningocele.

Neurosurgical review·1999
Same author

Arachnoid cysts: how do postsurgical cyst size and seizure outcome correlate?

Neurosurgical review·1998
Same author

Endo-neuro-sonography: principles of 3-D technique.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·1998

Area of Science:

  • Minimally Invasive Spine Procedures
  • Interventional Pain Management
  • Biochemical Disc Treatment

Context:

  • Chemonucleolysis (CNL) has been utilized since 1963 as an adjunct to surgical interventions for lumbar disc herniation.
  • Global success rates for CNL treatments are reported around 70%, with approximately 20% requiring subsequent surgical correction.
  • This study reviews institutional experience with CNL in managing lumbar disc prolapses.

Purpose:

  • To evaluate the efficacy and outcomes of Chemonucleolysis (CNL) as a treatment for lumbar disc herniation.
  • To determine the rate of surgical intervention following CNL therapy.
  • To assess the role of CNL as a potential alternative to surgery in specific patient populations.

Summary:

  • The study reports a 70% success rate with Chemonucleolysis (CNL) in their patient cohort, aligning with international benchmarks.
  • The frequency of subsequent operations was approximately 18%, consistent with global standards.
  • CNL is presented not as a definitive substitute for surgery but as a viable option to obviate surgical intervention in carefully selected cases with precise indications.

Impact:

  • Chemonucleolysis (CNL) offers a minimally invasive option for lumbar disc herniation, potentially reducing the need for open surgery.
  • Successful CNL outcomes can improve patient quality of life and reduce healthcare costs associated with surgical procedures.
  • This evidence supports the continued consideration of CNL in the treatment algorithm for selected lumbar disc herniation patients.

Related Experiment Videos